Kenneth Nilsson

Q: What Schools Are Affiliated With Kenneth Nilsson

Kenneth Nilsson is affiliated with the following schools: Uppsala University, Karolinska Institute

Kenneth Nilsson's AcademicInfluence.com Rankings

Kenneth Nilsson

Medical

#1285

World Rank

#1608

Historical Rank

Hematology

#16

World Rank

#17

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Kenneth Nilsson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kenneth Nilsson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Establishment and characterization of a human histiocytic lymphoma cell line (U‐937) (1976) (2399)
Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas (1976) (800)
K562—A human erythroleukemic cell line (1979) (435)
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. (1970) (374)
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines (1976) (367)
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV (1971) (350)
Classification and biological nature of established human hematopoietic cell lines (1975) (341)
Stem cell factor is a chemotactic factor for human mast cells. (1994) (301)
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. (1974) (293)
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. (1996) (284)
Phenotypic Characterization of the Human Mast‐Cell Line HMC‐1 (1994) (277)
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. (1999) (277)
Phenotypic changes of human neuroblastoma cells in culture induced by 12‐O‐tetradecanoyl‐phorbol‐13‐acetate (1981) (271)
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells (1980) (245)
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. (1983) (235)
Human mast cells express functional TrkA and are a source of nerve growth factor (1997) (218)
Tumorigenicity of human hematopoietic cell lines in athymic nude mice (1977) (213)
Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. (1992) (213)
Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. (1996) (196)
Natural killer cells kill tumour cells at a given stage of differentiation (1981) (193)
Monocytes and Macrophages (1996) (171)
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. (2004) (169)
IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells. (2006) (164)
Formation and growth of multicellular spheroids of human origin (1983) (164)
Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. (1994) (163)
Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. (1982) (159)
Establishment and characteristics of two unique cell lines from patients with lymphosarcoma (1974) (152)
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model. (2006) (149)
Expression and function of chemokine receptors in human multiple myeloma (2003) (147)
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. (1992) (144)
Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. (1987) (135)
Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. (1993) (134)
Expression of CCL5/RANTES by Hodgkin and Reed‐Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue (2003) (133)
Mast cells express functional CD30 ligand and are the predominant CD30L‐positive cells in Hodgkin's disease (2001) (128)
Production of β2‐Microglobulin by Normal and Malignant Human Cell Lines and Peripheral Lymphocytes (1974) (125)
Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27Kip1 (2002) (125)
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c‐kit proto‐oncogene (2003) (118)
The Nature of Lymphoid Cell Lines and Their Relationship to the Virus (1979) (118)
T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. (1989) (117)
High‐frequency establishment of human immunoglobulin‐producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood (1971) (116)
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. (1994) (116)
Kinetics and concentration effects of TPA-induced differentiation of cultured human neuroblastoma cells. (1983) (113)
Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). (1997) (112)
Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. (1994) (111)
A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. (1995) (110)
Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. (2009) (106)
Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. (1985) (102)
Karyotypic characterization of established cell lines and short-term cultures of human lung cancers. (1985) (101)
Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. (1988) (96)
Helix pomatia A hemagglutinin: selectivity of binding to lymphocyte surface glycoproteins on T cells and certain B cells (1978) (95)
Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. (1982) (93)
Polycomb Target Genes Are Silenced in Multiple Myeloma (2010) (93)
Involvement of lymphoid and nonlymphoid cells in the production of beta2-microglobulin-a homologue of the constant domains of IgG. (1973) (92)
Specific changes in the surface glycoprotein pattern of human promyelocytic leukemic cell line HL-60 during morphologic and functional differentiation. (1979) (91)
Expression of the bcl‐2 family of pro‐ and anti‐apoptotic genes in multiple myeloma and normal plasma cells (2002) (87)
Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines. (1998) (86)
Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. (1996) (86)
Differential expression of platelet‐derived growth factor and transforming growth factor genes in small‐ and non‐small‐cell human lung carcinoma lines (1988) (86)
Retinoic Acid Receptor/Retinoid X Receptor Heterodimers Can Be Activated through Both Subunits Providing a Basis for Synergistic Transactivation and Cellular Differentiation* (1997) (86)
Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines. (1986) (85)
β2-Microglobulin Production in Vitro by Human Hematopoietic, Mesenchymal, and Epithelial Cells (1974) (82)
Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. (1985) (81)
Characteristics of established myeloma and lymphoblastoid cell lines derived from an e myeloma patient: A comparative study (1971) (79)
Growth of diploid, epstein‐barr virus‐carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions (1979) (77)
Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. (1998) (74)
Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. (1985) (73)
Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation. (1984) (73)
Surface receptors on human haematopoietic cell lines. (1976) (73)
Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells. (1987) (72)
Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. (1994) (71)
Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts (1993) (71)
Targeting the IGF‐1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival (2007) (70)
Induction of platelet‐derived growth factor gene expression during megakaryoblastic and monocytic differentiation of human leukemia cell lines. (1987) (70)
Detection and quantitation of IgG on the surface of human lymphoid cells by rosette formation with protein A‐coated sheep red blood cells (1974) (69)
Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells. (2000) (69)
Natural cytotoxicity to human leukemia mediated by mouse non‐t cells (1977) (69)
Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells. (2003) (68)
Characteristics of Epstein-Barr virus activation of human B lymphocytes (1981) (67)
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. (1981) (67)
Beta 2-microglobulin in chronic lymphocytic leukaemia. (2009) (66)
Monocytic origin of the human hematopoietic cell line U‐937 and its convertibility to macrophages evidenced by isoenzyme mapping (1983) (62)
Lack of oxygen effect in glutathione-deficient human cells in culture. (1980) (61)
Microcarrier cell culture. (1988) (61)
Human B-lymphoid cell lines. (1992) (61)
Phosphorylation-deficient Stat1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. (2000) (61)
Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B‐type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signals (1989) (60)
Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma. (2009) (60)
In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. (1991) (59)
Neuron-specific enolase in relation to differentiation in human neuroblastoma (1981) (59)
Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and epstein‐barr virus (EBV)‐positive and ‐negative B lymphoid cell lines (1977) (59)
Surface glycoprotein patterns of normal and malignant human lymphoid cells. I. T cells, T blasts and leukemic T cell lines (1977) (59)
Constitutive and Inducible Cytokine mRNA Expression in the Human Mast Cell Line HMC‐1 (1995) (58)
Establishment and characterization of a continuous lung squamous cell carcinoma cell line (U-1752). (1981) (56)
IL-6 as a growth factor for human multiple myeloma cells--a short overview. (1990) (56)
Neuron specific enolase: a marker for differential diagnosis of neuroblastoma and Wilms' tumor. (1982) (55)
Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target (2016) (55)
Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). (2002) (54)
Identification of Cell Surface Immunoglobulin Markers by Protein A‐Containing Fluorescent Staphylococci (1974) (54)
Mammalian cell culture. (1987) (54)
Immunoglobulin synthesis and glucose-6-phosphate dehydrogenase as cell markers in human lymphoblastoid cell lines. (1974) (52)
Phenotypic characterization of KU812, a cell line identified as an immature human basophilic leukocyte (1992) (51)
EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions (2016) (51)
Establishment and phenotypic characterization of three new human myeloma cell lines (U-1957, U-1958, and U-1996). (1987) (51)
Interferon gamma abrogates the differentiation block in v-myc-expressing U-937 monoblasts. (1991) (50)
Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. (1991) (50)
Increase in interleukin 6 (IL-6) and IL-6 receptor expression in a human multiple myeloma cell line, U-266, during long-term in vitro culture and the development of a possible autocrine IL-6 loop. (1992) (50)
Cell cycle progression of B-chronic lymphocytic leukemia cells induced to differentiate by TPA. (1988) (47)
Accessory function of human tumor cell lines I Production of interleukin 1 by the human histiocytic lymphoma cell line U‐937 (1982) (47)
Expression of the endogenous retrovirus ERV3 (HERV‐R) during induced monocytic differentiation in the U‐937 cell line (1996) (46)
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy (2013) (46)
Identification of a cell‐surface glycoprotein mediating cell adhesion in EBV‐immortalized normal B cells (1986) (46)
Blood Dendritic Cells From Myeloma Patients Are Not Infected With Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) (1998) (45)
Interferon therapy in multiple myeloma. (2009) (44)
Cytochemical Profile of Human Haematopoietic Biopsy Cells and Derived Cell Lines (1977) (43)
Establishment and characterization of two neoplastic cell lines (U-1285 and U-1568) derived from small cell carcinoma of the lung. (2009) (43)
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma. (2008) (40)
Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia (1980) (40)
Molecular investigation of the cytokines produced by normal and malignant B lymphocytes. (1992) (40)
The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines. (1999) (40)
Expression of a Mast Cell Tryptase in the Human Monocytic Cell Lines U‐937 and Mono Mac 6 (1993) (40)
Movement of IgG receptors on the lymphocyte surface induced by protein A of Staphylococcus aureus. (1974) (40)
Stem cell factor‐dependent human cord blood derived mast cells express α‐ and β‐tryptase, heparin and chondroitin sulphate (1996) (39)
Blood dendritic cells from myeloma patients are not infected with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). (1998) (39)
Development of immunocytes and immunoglobulin production in long‐term cultures from normal and malignant human lymph nodes (1968) (38)
Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia (1980) (38)
The role of Bcl-2 in the pathogenesis of B chronic lymphocytic leukemia. (1993) (37)
Neuron-specific enolase as a marker for neuroblastoma and small-cell carcinoma of the lung. (1984) (37)
Recombinant interferon‐ γ inhibits the growth of IL‐6‐dependent human multiple myeloma cell lines in vitro (1991) (37)
Enhancement of Human Immunodeficiency Virus (HIV) Replication in Human Monocytes by Low Titres of Anti‐HIV Antibodies in Vitro (1989) (36)
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia. (2004) (36)
Demonstration of mast‐cell chemotactic activity in nasal lavage fluid: characterization of one chemotaxin as c‐kit ligand, stem cell factor (1998) (36)
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia (2006) (36)
The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. (1995) (35)
Lysis of fresh human B‐lymphocyte‐derived leukemia cells by interferon‐activated natural killer (NK) cells (1982) (35)
Synthesis and secretion of IgE by an established human myeloma cell line. (1971) (35)
Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro. (1982) (35)
Characterization of a Human Basophil‐Like Cell Line (LAMA‐84) (1996) (35)
Phorbol ester-induced alteration of differentiation and proliferation in human hematopoietic tumor cell lines: relationship to the presence and subcellular distribution of protein kinase C. (1985) (34)
Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. (1996) (33)
Association of extracellular matrix proteins fibulin‐1 and fibulin‐2 with fibronectin in bone marrow stroma (2000) (33)
Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells. (1991) (33)
TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812. (1994) (33)
Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours. (1994) (32)
Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. (1989) (32)
Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K‐562 and U‐937 cell lines induced by chelators and their iron complexes (1987) (32)
Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis. (1988) (31)
Differentiation-associated changes in the expression of chondroitin sulfate proteoglycan in induced U-937 cells. (1988) (31)
Established cell lines as tools in the study of human lymphoma and myeloma cell characteristics. (1977) (31)
Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia (1987) (31)
Lectin agglutinability of non‐neoplastic and neoplastic human lymphoid cells in vitro (1975) (31)
Effects of recombinant interferon-alpha and -gamma on B-CLL cells in serum-free medium: expression of activation, differentiation, and CALLA antigens. (1987) (30)
Macrophages and the cytokine network. (1993) (30)
SDZ PSC‐833—a novel potent in vitro chemosensitizer in multiple myeloma (1992) (30)
Synthesis of thromboplastin by U‐937 cells (1982) (30)
Amplification of the N‐myc oncogene in an adenocarcinoma of the lung (1986) (29)
An established Burkitt's lymphoma line with cell membrane IgG. (1975) (29)
Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH). (2009) (29)
The control of proliferation, survival and apoptosis in human multiple myeloma cells in vitro. (1999) (29)
CD49f (alpha 6 integrin) and CD66a (BGP) are specifically induced by retinoids during human monocytic differentiation. (1995) (28)
Presence of alpha-naphthyl acetate esterase activity in human haematopoietic cell lines and in fresh biopsy specimens of lymphoma and myeloma. (2009) (28)
Retinoic acid – induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p 27 Kip 1 (2002) (27)
Independent expression of the two HL‐A antigen polypeptide chains (1975) (27)
Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells. (1996) (27)
Thromboplastin as a marker for monocyte differentiation (1983) (27)
Isolation of MYADM, a novel hematopoietic‐associated marker gene expressed in multipotent progenitor cells and up‐regulated during myeloid differentiation (2000) (27)
Expression of the proenkephalin gene in human neuroblastoma cell lines. (1988) (27)
Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U‐937 lymphoma cell line without overexpression of the 170‐KDa P‐glycoprotein (1994) (27)
3H-thymidine uptake in chronic lymphocytic leukaemia cells. (2009) (26)
Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase- and chymase-positive mast cells. (2003) (26)
Evidence for separate control by phorbol esters of CD18-dependent adhesion and translocation of protein kinase C in U-937 cells. (1988) (26)
IFN-γ-induced upregulation of Fcγ-receptor-i during activation of monocytic cells requires the PKR and NFκB pathways (2007) (26)
Iron metabolism of established human hematopoietic cell lines in vitro. (1983) (25)
Induction of Basophilic Differentiation in the Human Basophilic Cell Line KU812 (1988) (25)
Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells. (2005) (24)
Quantitation of beta2-microglobulin and HLA on the surface of human cells. II. In vitro cell lines and their hybrids. (1977) (24)
Reactivity of smooth-muscle antibodies, surface ultrastructure, and mobility in cells of human hematopoietic cell lines. (1975) (24)
Biochemical characteristics of chronic lymphocytic leukaemia. Glucocorticoid receptors, B and T lymphocyte surface markers, concanavalin A-induced agglutination and thymidine incorporation. (2009) (24)
Quantitation of beta2-microglobulin and HLA on the surface of human cells. I. T and B lymphocytes and lymphoblasts. (1977) (23)
Myeloperoxidase mediates cell adhesion via the α M β 2 integrin ( Mac-1 , CD 11 b / CD 18 ) (1997) (23)
Interleukin‐4 (IL‐4) Enhances Homotypic Adhesion of Activated B‐Chronic Lymphocytic Leukaemia (B‐CLL) Cells via a Selective Up‐Regulation of CD54 (1993) (23)
Flt3 ligand induces the outgrowth of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes. (1999) (22)
The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia (2011) (22)
Expression of myc‐family genes in established human multiple myeloma cell lines: L‐myc but not c‐myc gene expression in the U‐266 myeloma cell line (1992) (21)
Interferon‐γ cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells (2001) (21)
Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). (2007) (21)
Cell surface characteristics of human histiocytic lymhoma lines--I. Surface glycoprotein patterns. (1980) (21)
The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains (2017) (21)
Radiation effects on cultured human lymphoid cells. Analysis using the growth extrapolation method. (1981) (21)
In Search of α1-Microglobulin on the Lymphocyte Surface (1979) (21)
Radiosensitivity of human B-lymphocytic lymphomas in vitro. (1982) (21)
Cytotoxic effect of calcein acetoxymethyl ester on human tumor cell lines: drug delivery by intracellular trapping. (1995) (21)
Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells. (1993) (20)
Activation of human T lymphocytes by 12-O-tetradecanoylphorbol-13-acetate: role of accessory cells and interaction with lectins and allogeneic cells. (1982) (20)
Multiple Myeloma Cell Lines (2002) (20)
Immunoglobulin synthesis in the human myeloma cell line U‐266; expression of two immunoglobulin heavy chain isotypes (ϵ and α) after long‐term cultivation in vitro (1988) (20)
Column separation of monocytes by adherence to gelatin beads. (1983) (20)
Induction of differentiation in U‐937 and NB4 cells is associated with inhibition of tissue factor production (1999) (20)
Expression of immunoglobulin synthesis in human myeloma x non-lymphoid cell heterokaryons: evidence for negative control. (1976) (20)
The effects on growth and survival of IL‐6 can be dissociated in the U‐266‐1970/U‐266‐1984 and HL407E/HL407L human multiple myeloma cell lines (1997) (20)
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma (2012) (20)
Establishment and characterization of a human EBV-negative B cell line (MN 60). (1982) (20)
Large-scale protein profiling in human cell lines using antibody-based proteomics. (2011) (19)
Use of a promoter-trap retrovirus to identify and isolate genes involved in differentiation of a myeloid progenitor cell line in vitro. (1996) (18)
IFN-gamma-induced upregulation of Fcgamma-receptor-I during activation of monocytic cells requires the PKR and NFkappaB pathways. (2007) (18)
The dynamic morphology of the transferrin-transferrin receptor system in human leukaemia/lymphoma cell lines and its relation to iron metabolism and cell proliferation. (2009) (18)
Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia (2005) (18)
Lysis of human B‐lymphocyte‐derived lymphoma/leukemia cells of established cell lines by interferon‐activated natural killer (NK) cells (1981) (18)
A human lymphoid cell line with an IgG‐like membrane component (1975) (17)
Tissue and differentiation specific expression on the endogenous retrovirus ERV3 (HERV-R) in normal human tissues and during induced monocytic differentiation in the U-937 cell line. (1997) (17)
Cytotoxic effect in vivo and in vitro of CHS 828 on human myeloma cell lines (2004) (17)
Molecular characterization of neoplastic and normal “sister” lymphoblastoid B-cell lines from chronic lymphocytic leukemia (2013) (17)
A human neoplastic hematopoietic cell line producing a fibroblast type of interferon. (1979) (17)
Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients. (2000) (17)
Chronic estrogen deficiency leads to molecular aberrations related to neurodegenerative changes in follitropin receptor knockout female mice (2002) (17)
The role of RAR and RXR activation in retinoid-induced tissue factor suppression (2000) (17)
Cytokine-induced restoration of differentiation and cell cycle arrest in v-Myc transformed U-937 monoblasts correlates with reduced Myc activity (2001) (16)
Glucocorticoid receptors, DNA synthesis, membrane antigens and their relation to disease activity in chronic lymphatic leukemia. (1976) (16)
The effect of α and γ‐interferon on proliferation and production of IgE and β2‐microglobulin in the human myeloma cell line U‐266 and in an α‐interferon resistant U‐266 subline (1986) (16)
Cytogenetic studies on human myeloma cell lines (1987) (16)
Demonstration of specific high‐affinity Fcɛ‐receptors on the human basophil‐like leukemia cell line KU812 by flow cytometry (1995) (15)
Cell surface characteristics of human histiocytic lymphoma cell lines. II. Expression of Helix pomatia A hemagglutinin binding surface glycoproteins, HLA-DR and common acute lymphocytic leukemia (cALL) antigen. (1981) (15)
Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia (1982) (15)
Tropism for primary monocytes and for monocytoid cell lines are separate features of HIV‐1 variants (1994) (15)
Differentiation-associated redox-regulation in human B cell lines from stem cell/pro-B to plasma cell. (2004) (15)
Tissue factor expression in human monocytic cell lines. (1997) (14)
Characterization of A U‐937 subline which can be induced to differentiate in serum‐free medium (1992) (14)
Glycosidase and phosphatase activities in U-937 and some clones and sublines. (1988) (14)
Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells (1997) (14)
Natural killer (NK) cell sensitivity of phorbol ester‐differentiated tumour cells correlates with disease activity in chronic B‐lymphocytic leukaemia (1982) (14)
Cytoplasmic pH is differently regulated in the monoblastic U-937 and erythroleukemic K-562 cell lines. (1988) (13)
Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages. (1998) (13)
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia (2004) (13)
Establishment of a new human myeloma cell line (u‐2030) and selection of a hat‐sensitive subline (1987) (13)
Establishment of multiple lymphoblastoid lines from single lymph nodes and study of their immunoglobulin synthesis (1973) (13)
Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene. (2008) (13)
Inhibition of Monocytic Differentiation by Phosphorylation‐deficient Stat1 is Associated with Impaired Expression of Stat2, ICSBP/IRF8 and C/EBPɛ (2006) (13)
Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance. (1998) (13)
Rosette formation with goat erythrocytes. A marker for human T lymphocytes. (1978) (13)
Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester. (1988) (13)
Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells. (1985) (13)
Diploid human lymphoblastoid and burkitt lymphoma cell lines: Susceptibility to murine NK cells and heterotransplantation to nude mice (1981) (13)
Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia. (2009) (12)
The Transcriptomic and Proteomic Landscapes of Bone Marrow and Secondary Lymphoid Tissues (2014) (12)
Human Malignant Lymphomas in Vitro (1978) (12)
Phenotypic and cytogenetic characteristics of a new epstein‐barr virus negative cell line (SKW 4) derived from A B‐Cell lymphoma (2007) (12)
The potential of human mast cell progenitors to differentiate into mature mast cells remains after prolonged culture with flt3 ligand, interleukin‐3 or granulocyte‐macrophage colony stimulating factor (1999) (12)
Characteristic Surface Morphology of Human and Murine Myeloma Cells: a Scanning and Transmission Electron Microscopic Study (1978) (11)
CD40 Ligation Inhibits IL‐2 and SAC+IL‐2 Induced Proliferation in Chronic Lymphocytic Leukaemia Cells (1997) (11)
Cell surface glycoprotein changes in Epstein‐Barr virus‐positive and ‐negative human hematopoietic cell lines (1979) (11)
Mg2+- and Ca2+-stimulated ATPase at the outer surface of human peripheral lymphocytes and hematopoietic cell lines. Correlation between enzyme activity and immunoglobulin secretion. (1976) (11)
The effect of alpha and gamma-interferon on proliferation and production of IgE and beta 2-microglobulin in the human myeloma cell line U-266 and in an alpha-interferon resistant U-266 subline. (1986) (11)
Presence of erythrocytic components in the K562 cell line (1979) (10)
A Nonclonogenic Cytotoxicity Assay Using Primary Cultures of Patient Tumor Cells for Anticancer Drug Screening (1998) (10)
Surface glycoprotein patterns of B type chronic lymphocytic leukaemia cells correlate with the clinical activity of the disease. (2009) (10)
Tumor-initiating cells in childhood neuroblastoma--letter. (2012) (10)
Immunoglobulin synthesis in the human myeloma cell line U-266; expression of two immunoglobulin heavy chain isotypes (epsilon and alpha) after long-term cultivation in vitro. (1988) (10)
An amplification technology for improving sensitivity when measuring components in biological samples. (1988) (9)
Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragments. (1989) (9)
Selective cytotoxic activity of cyclosporins against tumor cells from patients with B cell chronic lymphocytic leukemia. (1992) (9)
Recombinant interferon-gamma inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro. (1991) (9)
Surface glycoproteins of human non-T, non-B acute lymphocytic leukemia cell lines. (1980) (9)
Cell lines with spontaneous secretion of pregnancy‐associated α2‐globulin (1979) (9)
Quantitation of β2‐Microglobulin and HLA on the Surface of Human Cells (1977) (8)
Plasma Cell and Myeloma Cell Lines (2000) (8)
ANALYSIS OF DIFFERENTIATION EVENTS CAUSING CHANGES IN NK CELL TUMOR-TARGET SENSITIVITY (1982) (8)
Differentiation and activation associated expression of IL-6 and IL-6 receptors in U-937 monocytic cells: relationship to the expression of CD14. (1992) (8)
Early ionic events associated with phorbol ester induced differentiation and inhibition of cell growth in hematopoietic tumor cell lines. (1989) (8)
BCL-2 in B-chronic lymphocytic leukemia. (1992) (8)
PHORBOL ESTER- AND ANTI-IgM-INDUCED DIFFERENTIATION OF HUMAN NEOPLASTIC B LYMPHOCYTES: MODULATION OF Ig SECRETION BY ACCESSORY CELLS AND CHANGES IN THE NK CELL SENSITIVITY OF TUMOR CELLS (1982) (8)
PML/RARalpha plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells. (2003) (8)
Early changes in the glycopeptides of human B‐lymphocytes after epstein‐barr virus infection in vitro (1981) (8)
Cytoplasmic levels of IgE(Δ) in human myeloma cells in the different phases of the cell cycle (1977) (8)
Phorbol ester‐induced production of beta‐2‐microglobulin in B‐CLL cells: relation to IgM secretory response and disease activity (1986) (8)
Effects of interferons and tumour necrosis factor-alpha on human lung cancer cell lines and the development of an interferon-resistant lung cancer cell line. (1996) (8)
Short‐Term Tissue Culture of Two Nonsecretory Human Myelomas (1976) (7)
Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies (1997) (7)
Hybridization of a human myeloma permanent cell line with mouse cells. (1976) (7)
Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes (1978) (7)
Radiation sensitivity of human histiocytic lymphomas in vitro. (1983) (7)
Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562 (reply) (1979) (7)
Conditioned media from cultured blood cells of atopic individuals can induce differentiation in the human basophilic leukemia cell line KU812. (1989) (7)
Effects of prednisolone in 6 cases of glucocorticoid receptor-positive CLL. (2009) (7)
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy (2013) (7)
C-Jun is Induced to High Continuous Expression During Differentiation of Hematopoietic Cells and is Regulated Independently from C-Fos. (1991) (7)
Density gradient separation of lymphoid cells adhering to protein-A-containing staphylococci. (1974) (7)
Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells. (1984) (6)
The retrovirus particles in human myeloma cells RPMI8226: morphological, biochemical, immunological and infective transmission studies. (1978) (6)
Cell surface glycoprotein patterns of cell lines derived from human small cell carcinoma of the lung. (2009) (6)
Cellular origin of the chemokinetic inhibitor of polymorphononuclear leucocytes found in sera from patients with chronic lymphocytic leukaemia. (2009) (6)
Ectopic expression of myc or myn down-regulates immunoglobulin transcription. (1994) (6)
PML/RARα plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells (2003) (6)
Beta 2-microglobulin production in vitro by human hematopoietic, mesenchymal, and epithelial cells. (1974) (6)
Ser 727 / Tyr 701-phosphorylated Stat 1 is required for the regulation of c-Myc , cyclins , and p 27 Kip 1 associated with ATRA-induced G 0 / G 1 arrest of U-937 cells (2003) (6)
On the role of endogenously produced TNF-alpha and IL-6 as regulators of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro. (1992) (6)
Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myeloma (2012) (6)
Neuron Specific Enolase: A Marker for Differential Diagnosis of Neuroblastoma and Wilms’ Tumor (1983) (5)
SURFACE SIALIC ACID OF TUMOR CELLS INVERSELY CORRELATES WITH SUSCEPTIBILITY TO NATURAL KILLER CELL MEDIATED LYSIS (1982) (5)
Concentration-dependent effects of hematopoietic growth factors during in vitro expansion of mouse stem cells and progenitor cells. (1997) (5)
Expression of c-myc and c-fos during phorbol ester induced differentiation of B-type chronic lymphocytic leukemia cells. (1986) (5)
Surface-glycoprotein patterns of established human lung cancer cell lines and primary cultures. (1985) (5)
Immobilization of proteins by entrapment in polyacrylamide microbeads. (1982) (5)
Specific binding of B‐CLL cell‐derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes (1987) (5)
The Chemokinetic Inhibitory Factor Derived from Chronic Lymphocytic Leukaemia Cells (1986) (5)
Human hematopoietic cells in continuous culture (1971) (5)
Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination. (1989) (5)
Selective Inhibition of Glycogen Synthase Kinase-3 by Facilitators of Insulin Response Promotes Proliferation and Survival in Multiple Myeloma Cells. (2007) (5)
Subcellular characterization of the transferrin-transferrin receptor and iron accumulating system of established human erythroid and monoblastoid tumour cell lines. (2009) (4)
Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828 (2004) (4)
Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes. (1986) (4)
Detection of oncornavirus-like particles in human cell lines derived from tumours of hemopoietic tissue. (1974) (4)
TPA-induced differentiation of chronic lymphocytic leukemia cells: studies on mu-chain expression. (1987) (4)
Enhancement of IgE Synthesis in the Human Myeloma Cell Line U‐266 with an IgE Binding Factor from a Human T‐Cell line (1991) (4)
TPA induces cytoplasmic alkalinization in human monoblastic U-937 cells without activation of Na+/H+ exchange. (1987) (4)
Modulation of SCE frequencies in cell lines derived from human B and T lymphocytes. (2008) (4)
Interleukin-1 beta induces cyclic AMP formation in isolated human osteoblasts: a signalling mechanism that is not related to enhanced prostaglandin formation. (1994) (4)
Isotype-specific suppression of IgE synthesis in a human myeloma cell line (U-266) by an IgE-binding protein derived from normal human peripheral blood cells. (1989) (3)
Chronic B-lymphocytic leukemia--expression of B cell activation markers in relation to activity of the disease. (1988) (3)
Patterns of glycosidases in the histiocytic cell line U-937. Effects of agents inducing cell differentiation. (1988) (3)
[Neopterin, a new biochemical marker for clinical assessment of cell-mediated immune response]. (1984) (3)
Phorbol ester (TPA)-induced differentiation of B-type chronic lymphocytic keulemia cells (1985) (3)
Increased endocytosis and formation of multivesicular bodies in phorbol ester-stimulated human monoblastic U-937 cells. (1989) (3)
Mouse red cell receptors on human hematopoietic cell lines. (1980) (3)
Differentiation associated c-myc expression in phorbol ester and lymphokine stimulated B-type chronic lymphocytic leukemia cells. (1988) (2)
Immunocytometric characteristics of a monoclonal antibody (Bra55) recognizing the leukocyte common antigen (LCA). (1988) (2)
Transcriptional regulation of immunoglobulin expression in a chronic lymphocytic leukemia cell line (1989) (2)
The Fibroblast Mitogenic Activity Released from Human Basophilic Cell Line KU812 is Separate from Tryptase and PDGF Expression (1996) (2)
Phorbol‐ester‐induced stable changes in the regulation of DNA synthesis and intracellular pH are accompanied by altered expression of protein kinase C in the monoblastoid cell line U‐937 (1988) (2)
Modulation of calcium signalling and proliferation in monoblastoid U-937 cells. (1996) (2)
Phorbol ester treatment down-regulates immunoglobulin RNA steady-state levels in B type chronic lymphocytic leukemia and non-Hodgkin's lymphoma cells. (1990) (2)
[Effect of heat shock on cell differentiation and apoptosis in U-937 cells]. (2000) (2)
Expression of FcIgG-receptor (FcIgG-r) sites on the surface of neoplastic lymphocytes. (1977) (2)
Suppression of basal, PMA‐and IFN‐α‐, but not IFN‐γ‐induced expression of HLA class I in v‐myc‐transformed U‐937 monoblasts (1992) (2)
Meeting abstractInduced differentiation in human leukaemia/lymphoma cell lines. A short overview (1987) (2)
Control of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro. (1992) (1)
Effect of calcein acetoxymethyl ester on human tumor cell lines: Cytotoxic drug delivery by intracellular trapping. (1995) (1)
Polyacrylamide microbeads with entrapped protein A from S. aureus for cell separation. (2009) (1)
Targeting the Insulin-Like Growth Factor-I Receptor (IGF-IR) in Multiple Myeloma Cells Using Selective IGF-IR Tyrosine Kinase Inhibitors. (2004) (1)
Surface glycoprotein patterns of human haematopoietic cell lines. (1978) (1)
The expression of proteoglycans in phorbol ester induced U-937 cells (1988) (1)
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma (2012) (1)
Production of β2‐microglobulin by chronic lymphocytic leukaemia cells in vitro (2009) (1)
Cytokine-induced inhibition of Myc activity in monocytic cells. (1997) (1)
KINETICS OF PRODUCTION AND RELEASE OF NEOPTERIN. COMPARISON OF HUMAN PBMC WITH THE PERMANENT MONOCYTIC CELL LINE U937 AND ITS SUBCLONES. (1987) (1)
in vitro and in vivo study in the 5T33MM mouse model Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an (2013) (1)
In search of alpha 1-microglobulin on the lymphocyte surface. (1979) (1)
IgE‐producing low‐grade non‐Hodgkin lymphoma (1988) (1)
Expression and specificity of FcIgG receptor sites on neoplastic lymphocytes. (1978) (1)
B-cell Differentiation and Characterization (1980) (1)
Production of beta 2-microglobulin by chronic lymphocytic leukaemia cells in vitro. (1986) (1)
TNFα induces a reduction of histone 3 lysine 9 trimethylation and dimethylation (H3K9me2 and H3K9me2) at all-trans retinoic acid target genes (2008) (0)
Autophosphorylation at the outer surface of different human cells in culture. (1981) (0)
An Epigenomic Map of Multiple Myeloma Reveals the Importance of Polycomb Gene Silencing for the Malignancy (2014) (0)
The Role of Insulin-Like Growth Factor-I Receptor/Akt/Glycogen Synthase Kinase-3β Pathway in Survival of Multiple Myeloma Cells (2003) (0)
C in U-937 Cells KinaseCD 18-dependent Adhesion and Translocation of Protein Evidence for Separate Control by Phorbol Esters of Updated Version (2006) (0)
Suppression of basal, PMA- and IFN-alpha-, but not IFN-gamma-induced expression of HLA class I in v-myc-transformed U-937 monoblasts. (1992) (0)
Cytoplasmic levels of IgE (lambda) in human myeloma cells in the different phases of the cell cycle. (1977) (0)
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 166 Apoptosis Regulation in Multiple Myeloma (2006) (0)
Serine-727 phosphorylated Stat1 is required for ATRA-induced G0/G1 arrest and the associated regulation of cyclins and p27Kip1 (2002) (0)
Vitamin D3 and retinoic acid induced monocytic differentiation : Interactions between the endogenous vitamin D3, retinoic acid and retinoid X receptors in U-937 cells (1996) (0)
Sensitization to dexamethasone-induced apoptosis by abrogation of insulin-like growth factor (IGF)-I receptor signaling is associated with regulation of Inhibitors of apoptosis proteins (IAP) in human multiple myeloma cells (2006) (0)
The effect of Stat1 over-expression on the apoptosis-related gene profile and drug sensitivity of multiple myeloma cells (2006) (0)
Natural killer cells and their targets: impact of differentiation on target cell susceptibility. (1983) (0)
Inhibition of retinoic acid-induced differentiation of human monoblastic U-937 cells by phosphorylation deficient Stat1 is associated with impaired expression of Stat2, ICSBP and C/EBP-ε (2002) (0)
Quantitation of β2‐Microglobulin and HLA on the Surface of Human Cells (1977) (0)
Frontmatter (1987) (0)
Title: Smad4 modulates glycolysis and OXPHOS via interactions with PKM2 and ATPIF1 in diabetic nephropathy (2019) (0)
Cell lines with spontaneous secretion of pregnancy-associated alpha 2-globulin. (1979) (0)
Preferential replication of murine xenotropic type-C virus in human lymphosarcoma-derived cell lines. (1979) (0)
Activation of NFκB in all-trans retinoic acid induced differentiation, cell cycle arrest and p21 (CDKN1A/Waf1) expression in U-937 (2008) (0)
The Global Protein Expression Pattern in Human Cell Lines (2011) (0)
K562, an early erythroid or granulocytic cell line (1979) (0)
the stage of the disease T-cell activation and subset patterns are altered in B-CLL and correlate with (2011) (0)
Apoptosis Gene Expression Profiling in Chronic Lymphocytic Leukemia Using Multiplex Ligation-Dependent Probe Amplification. (2009) (0)
Abstract LB-366: Patient-derived EBV-immortalized B-lymphocytes are a dominant contaminant of in vitro cultured human neuroblastoma tumor-initiating cells isolated from bone marrow (2011) (0)
Fas/APO-1 (CD95)–Mediated Apoptosis Is Activated by Interferon- (cid:103) and Interferon- (cid:97) in Interleukin-6 (IL-6)–Dependent and IL-6–Independent Multiple Myeloma Cell Lines (1998) (0)
Targeting the Insulin-like Growth Factor Receptor (IGF-IR) Survival Pathways in Multiple Myeloma Using Selective IGF-IR Tyrosine Kinase Inhibitors (2003) (0)
The proteomic landscape of in vitro growth: A comparative analysis using antibody-based proteomics (2008) (0)
538 Induction of basophil propagation in the prebasophilic cell line KU-812 by conditioned media from cultured blood cells from allergic and non-allergic individuals (1988) (0)
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 283 Mechanisms of Sensitization to Apoptosis in Multiple Myeloma (2007) (0)
392 Mast cell chemoattractive activity in nasal lavage from allergic patients (1996) (0)
involved in differentiation of a myeloid progenitor cell line in vitro Use of a promoter-trap retrovirus to identify and isolate genes (2010) (0)
8CL-2 in 8-Chronic Lymphocytic Leukemia (1992) (0)
Anti-cancer drugcharacterisation using ahumancell line panel representing defined typesofdrugresistance (1996) (0)
Ubiquitous protein expression in human cells, tissues and organs (2008) (0)
Malignant melanoma in cattle - a case report (1998) (0)
ACTIVATION OF HUMAN B LYMPHOCYTES (1981) (0)
Open Discussion on the Biology of Multiple Myeloma. Chairman’s Introductory Remarks (1991) (0)
Stat1 involvement in retinoic acid induced differentiation of myeloid cells (2000) (0)
Characterization of two variants of a human mast cell line (HMC-1) with distinguished phenotypes and mutations in the c-kit proto-oncogene (2001) (0)
Independent Human Multiple Myeloma Cell Lines - Dependent and IL-6 - The Somatostatin Analog Octreotide Inhibits Growth of Interleukin-6 (IL-6) (2013) (0)
Potential Benefits and Hazards of Humoral Immune Reactions against HTLV-III. (1989) (0)
Binding of anti-idiotypic antibodies against human serum low density lipoprotein (LDL) to skin fibroblasts. (1980) (0)
273 IL-6 and TNFα induce maturation in the basophil like cell line KU812 (1991) (0)
Stemcell factor-dependent humancordbloodderived mastcells express x-and J-tryptase, heparin andchondroitin sulphate (1996) (0)
ABT-737 Sensitizes B Cell Tumors for Killing by CD19-Retargeted T Cells, (2011) (0)
Toward a rational combinaTORial therapy for multiple myeloma (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kenneth Nilsson?

Kenneth Nilsson is affiliated with the following schools:

Kenneth Nilsson's Academic­Influence.com Rankings

Why Is Kenneth Nilsson Influential?

Kenneth Nilsson's Published Works

Published Works

What Schools Are Affiliated With Kenneth Nilsson?

Kenneth Nilsson's AcademicInfluence.com Rankings